Literature DB >> 29095135

HTA IN CENTRAL-EASTERN-SOUTHERN EUROPE: FINDING ITS WAY TO HEALTH POLICY.

Anna Zawada1, Marjukka Mäkelä2.   

Abstract

The number of publications on health technology assessment (HTA) from Central, Eastern, and Southern Europe (CESE countries) is still low compared with the north and west of Europe. It is not surprising, as the idea of HTA originated from high-income Western economies and was afterward adopted by the south-eastern part of Europe, which mostly consists of middle-income countries. These CESE countries, with less capacity and experience with HTA processes, must deal with even tougher decisions on financing health technologies than north-western Europe. There may even be a lack of confidence to open discussions on their specific needs for HTA.

Mesh:

Year:  2017        PMID: 29095135     DOI: 10.1017/S0266462317000988

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  1 in total

1.  Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.

Authors:  Paweł Kawalec; Tomas Tesar; Lenka Vostalova; Pero Draganic; Manoela Manova; Alexandra Savova; Guenka Petrova; Zinta Rugaja; Agnes Männik; Christoph Sowada; Ewa Stawowczyk; Andras Harsanyi; Andras Inotai; Adina Turcu-Stiolica; Jolanta Gulbinovič; Andrzej Pilc
Journal:  Front Pharmacol       Date:  2017-12-18       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.